Sec. 8. (a) For substitution to occur for a prescription other than a prescription filled under the Medicaid program (42 U.S.C. 1396 et seq.), the children's health insurance program established under IC 12-17.6-2, the biosimilar biological products requirements under IC 16-42-25, or the Medicare program (42 U.S.C. 1395 et seq.):
(1) the practitioner must:
(A) sign on the line under which the words "May substitute" appear; or
(B) for an electronically transmitted prescription, electronically transmit the instruction "May substitute."; and
(2) the pharmacist must inform the customer of the substitution.
(b) This section does not authorize any substitution other than substitution of a generically equivalent drug product.
[Pre-1993 Recodification Citation: 16-6-8.1-2(c).]
As added by P.L.2-1993, SEC.25. Amended by P.L.239-1999, SEC.7; P.L.291-2001, SEC.233; P.L.204-2005, SEC.10; P.L.96-2014, SEC.5.
Structure Indiana Code
Article 42. Regulation of Food, Drugs, and Cosmetics
Chapter 22. Drugs: Generic Drugs
16-42-22-4. "Generically Equivalent Drug Product"
16-42-22-5.5. Limitation of Effect of Chapter
16-42-22-6. Prescription Forms
16-42-22-8. Requirements for Substitution
16-42-22-9. Transmission of Practitioner's Instructions to Pharmacist
16-42-22-10. Substitution Prohibited
16-42-22-11. Substitution of Generic Drugs; Identification of Brand Name Drug
16-42-22-12. Identification of Manufacturer or Distributor of Dispensed Drug Product on Prescription